Lundbeck acquires exclusive commercial rights to Sycrest outside U.S., China and Japan Oct. 13, 2010 No Comments
Novartis to use ImmunoGen's TAP technology to develop anticancer therapeutics Oct. 13, 2010 No Comments
Exelixis and Bristol-Myers Squibb collaborate on multiple small-molecule programs Oct. 13, 2010 No Comments
Amylin Pharma to use Affibody's Albumod platform under new license agreement Oct. 11, 2010 No Comments
BioRelix and Merck & Co. subsidiary partner to identify antibacterial drug candidates Oct. 7, 2010 No Comments